Lisata Therapeutics(LSTA) - 2024 Q1 - Earnings Call Presentation

Targeted Therapy Delivered David J. Mazzo, Ph.D. President and Chief Executive Officer Corporate Presentation| May 9, 2024 Nasdaq: LSTA www.lisata.com © Lisata Therapeutics, Inc. 2024. All rights reserved. Forward-looking statements advisory This presentation contains “forward-looking statements” that involve substantial risks and uncertainties for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, included ...